Innovent Biologics was founded seven years ago to ‘develop high quality drugs that are affordable to ordinary people’, according to the company’s co-founder and chairman Michael Yu Dechao. Photo: Reuters\

Will an up to US$500 million IPO by this Suzhou cancer drug developer be the harbinger of more to come to Hong Kong?

Topic |   IPO

TOP PICKS

Innovent Biologics was founded seven years ago to ‘develop high quality drugs that are affordable to ordinary people’, according to the company’s co-founder and chairman Michael Yu Dechao. Photo: Reuters\
READ FULL ARTICLE